Alumis Inc. Amends 8-K Filing
Ticker: ALMS · Form: 8-K/A · Filed: Jun 30, 2025 · CIK: 1847367
| Field | Detail |
|---|---|
| Company | Alumis Inc. (ALMS) |
| Form Type | 8-K/A |
| Filed Date | Jun 30, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: amendment, financial-statements, exhibits
TL;DR
Alumis Inc. filed an amendment to its 8-K, check for updates on financials/exhibits.
AI Summary
Alumis Inc. filed an amendment (8-K/A) on June 30, 2025, to a report originally dated May 21, 2025. This amendment pertains to financial statements and exhibits. The company, formerly known as Esker Therapeutics, Inc., is incorporated in Delaware and headquartered in South San Francisco, California.
Why It Matters
This filing is an amendment to a previous report, indicating a correction or addition to previously disclosed information, which could be material to investors.
Risk Assessment
Risk Level: low — This is a procedural amendment to a previous filing, not a new event or material disclosure.
Key Players & Entities
- Alumis Inc. (company) — Registrant
- Esker Therapeutics, Inc. (company) — Former Name
- May 21, 2025 (date) — Original Report Date
- June 30, 2025 (date) — Filing Date of Amendment
- 280 East Grand Avenue South San Francisco, California 94080 (address) — Principal Executive Offices
FAQ
What is the purpose of this 8-K/A filing?
This filing is an amendment (Amendment No. 1) to a Current Report on Form 8-K, specifically pertaining to Financial Statements and Exhibits.
When was the original report filed, and when was this amendment filed?
The original report was dated May 21, 2025, and this amendment was filed as of June 30, 2025.
What was Alumis Inc. formerly known as?
Alumis Inc. was formerly known as Esker Therapeutics, Inc.
Where is Alumis Inc. headquartered?
Alumis Inc.'s principal executive offices are located at 280 East Grand Avenue, South San Francisco, California 94080.
What is the SIC code for Alumis Inc.?
The Standard Industrial Classification code for Alumis Inc. is 2834, Pharmaceutical Preparations.
Filing Details
This Form 8-K/A (Form 8-K/A) was filed with the SEC on June 30, 2025 regarding ALUMIS INC. (ALMS).